Morgan Stanley Finance LLC Files 424B2 for Pricing Supplement No. 14,955

TL;DR

**Morgan Stanley Finance LLC just filed a routine prospectus for new securities, business as usual.**

AI Summary

Morgan Stanley Finance LLC filed a 424B2 prospectus on March 24, 2026, for Pricing Supplement No. 14,955, under its parent company Morgan Stanley. This filing is a routine update for a previously registered offering, likely related to asset-backed securities. For investors, this indicates ongoing financial activity and the potential for new debt instruments, which can impact the company's capital structure and future earnings.

Why It Matters

This filing signals Morgan Stanley Finance LLC's continued activity in the capital markets, potentially issuing new securities that could affect its funding costs and overall financial health.

Risk Assessment

Risk Level: low — This 424B2 filing is a standard prospectus update, indicating routine financial activity rather than a new, high-risk event.

Analyst Insight

Investors should view this as a routine operational update, indicating ongoing capital market activities. It doesn't suggest any immediate need for action but confirms the company's continued presence in issuing asset-backed securities.

Key Numbers

• 14,955 — Pricing Supplement Number (identifies the specific supplement being filed under the 424B2)
• 2026-03-24 — Filing Date (the date the 424B2 was filed with the SEC)
• 333-275587-01 — File No. for Morgan Stanley Finance LLC (the registration statement under which this prospectus supplement is filed)

Key Players & Entities

• Morgan Stanley Finance LLC (company) — the filer of the 424B2 prospectus
• Morgan Stanley (company) — the parent company of the filer
• March 24, 2026 (date) — the filing date of the 424B2
• Pricing Supplement No. 14,955 (dollar_amount) — the specific supplement being filed
• 0001666268 (company) — CIK of Morgan Stanley Finance LLC
• 0000895421 (company) — CIK of Morgan Stanley

Forward-Looking Statements

• Morgan Stanley Finance LLC will continue to issue asset-backed securities. (Morgan Stanley Finance LLC) — high confidence, target: 2027-03-24

FAQ

Key Financial Figures

• $5,975,000 — TS Opportunities in Global Equities $5,975,000 Digital iShares Expanded Tech-Softwar
• $1,150.00 — equal to the maximum settlement amount ($1,150.00 for each $1,000 face amount of your not
• $1,000 — m settlement amount ($1,150.00 for each $1,000 face amount of your notes). However, if
• $978.00 — he estimated value on the trade date is $978.00 per note. See "Estimated Value" on page
• $10.90 — roceeds to us (2) Per note $1,000 $10.90 $989.10 Total $5,975,000 $65,12
• $989.10 — o us (2) Per note $1,000 $10.90 $989.10 Total $5,975,000 $65,127.50 $5,
• $65,127.50 — $10.90 $989.10 Total $5,975,000 $65,127.50 $5,909,872.50 (1) Morgan Stanley &
• $5,909,872.50 — .10 Total $5,975,000 $65,127.50 $5,909,872.50 (1) Morgan Stanley & Co. LLC ("MS & C
• $82.99 — credit risk. Initial Underlier Level: $82.99 3 Final Underlier Level: The Closin
• $150.00 — 0 Face Amount plus an upside payment of $150.00) Threshold Level: $70.5415, which is
• $70 — payment of $150.00) Threshold Level: $70.5415, which is 85% of the Initial Under
• $1,000 M — Terms and Assumptions Face Amount: $1,000 Maximum Settlement Amount: $1,150.00 pe

Filing Documents

• ms14955_424b2-10605.htm (424B2) — 203KB
• ex-filingfees.htm (EX-FILING FEES) — 8KB
• image1.gif (GRAPHIC) — 56KB
• image2.gif (GRAPHIC) — 93KB
• 0001839882-26-016676.txt ( ) — 511KB
• ex-filingfees_htm.xml (XML) — 2KB

RISK FACTORS

RISK FACTORS This section describes the material risks relating to the notes. For further discussion of these and other risks, you should read the section entitled "Risk Factors" in the accompanying product supplement and prospectus. We also urge you to consult your investment, legal, tax, accounting and other advisers in connection with your investment in the notes. RISKS RELATING TO AN INVESTMENT IN THE NOTES The Notes Do Not Pay Interest Or Guarantee The Return Of Any Of Your Principal The terms of the notes differ from those of ordinary debt securities in that the notes do not pay interest and do not guarantee any return of principal at maturity. If the Final Underlier Level has declined by an amount greater than the Threshold Amount of 15% from the Initial Underlier Level, you will receive for each note that you hold a Cash Settlement Amount that is less than the Face Amount of each note by an amount proportionate to the decline in the level of the Underlier below the Threshold Level of 85% of the Initial Underlier Level times the Buffer Rate of approximately 117.65%. As there is no minimum Cash Settlement Amount on the notes, you could lose your entire initial investment. Also, the market price of your notes prior to the Stated Maturity Date may be significantly lower than the purchase price you pay for your notes. Consequently, if you sell your notes before the Stated Maturity Date, you may receive significantly less than the amount of your investment in the notes. The Appreciation Potential Of The Notes Is Limited By The Maximum Settlement Amount The appreciation potential of the notes is limited by the Maximum Settlement Amount of $1,150.00 per note, or 115.000% of the Face Amount. Because the Cash Settlement Amount will be limited to 115.000% of the Face Amount for the notes, any increase in the Final Underlier Level over the Threshold Level will not increase the return on the notes, even if the Final Underlier Level is significantly greater

View Full Filing

View this 424B2 filing on SEC EDGAR